Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios
F Lucà, F Oliva, MG Abrignani, SA Di Fusco… - Journal of Clinical …, 2023 - mdpi.com
It is well established that direct oral anticoagulants (DOACs) are the cornerstone of
anticoagulant strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and …
anticoagulant strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and …
Thrombin stories in the gut
N Vergnolle - Biochimie, 2024 - Elsevier
Many studies have demonstrated the involvement of proteases in gut physiology and
pathophysiology over the recent years. Among them, thrombin has appeared for a long time …
pathophysiology over the recent years. Among them, thrombin has appeared for a long time …
Adherence and clinical outcomes for twice-daily versus once-daily dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: Is dosing …
HJ Hwang, IS Sohn, ES Jin, YJ Bae - PLoS One, 2023 - journals.plos.org
Background Twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs)
may reduce drug adherence compared with once-daily dosing of NOACs in patients with …
may reduce drug adherence compared with once-daily dosing of NOACs in patients with …
Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation
SFB van der Horst, TAC de Vries, G Chu, R Bavalia… - TH Open, 2023 - thieme-connect.com
Background For most patients with newly diagnosed atrial fibrillation (AF), direct oral
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …